We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BELA:ATHEXJumbo S.A. Analysis

Data as of 2026-03-14 - not real-time

€23.38

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its 20‑day, 50‑day and 200‑day moving averages, confirming a bearish price bias. Momentum indicators show an RSI in the mid‑range, hinting at a potentially oversold condition. The MACD line sits beneath its signal line, producing a bearish histogram. Current price hovers just above a key support level, while resistance sits near the recent high. Volume has been on an upward trend, suggesting renewed market interest despite the downside bias. The 30‑day volatility is elevated, yet the beta remains low, indicating limited systematic risk.
Fundamentally, the company delivers solid profit margins and a healthy return on equity. Revenue is expanding at a modest single‑digit pace, outpacing many peers in the consumer cyclical space. Valuation metrics such as a low‑double‑digit PE and a price‑to‑book ratio around two point something point to an attractive entry point. The dividend yield sits above two percent with a payout ratio comfortably below fifty percent, supporting sustainability. A discounted cash‑flow model places fair value well above the current market price, implying a sizable upside. Analyst consensus leans toward a buy recommendation, and the market sentiment index reflects a greed‑driven environment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price trading below short‑term moving averages
  • RSI indicating near‑oversold condition
  • increasing volume suggesting potential reversal

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation gap to discounted cash‑flow fair value
  • strong profit margins and return on equity
  • sustainable dividend yield with moderate payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • long‑term upside potential relative to fair value
  • consistent earnings growth and dividend track record
  • low beta and defensive volatility profile

Key Metrics & Analysis

Financial Health

Revenue Growth8.00%
Profit Margin26.59%
P/E Ratio10.0
ROE23.65%
ROA14.49%
Debt/Equity4.96
P/B Ratio2.2
Op. Cash Flow€238.1M
Free Cash Flow€-4153920

Technical Analysis

TrendBearish
RSI36.4
Support€22.50
Resistance€26.24
MA 20€24.41
MA 50€25.59
MA 200€28.28
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value€25.99
Target Price€31.99
Upside/Downside36.82%
GradeUndervalued
TypeBlend
Dividend Yield2.17%

Risk Assessment

Beta0.28
Volatility25.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.